"With Syantra's #AI powered #RNA based #liquidbiopsy platform approach, Syantra is our partner of choice for molecular blood-based early #cancerdetection solutions." 🤝 - Bryan Ivory, President & CTO, Limmi
We're proud to share this exciting news... ⬇️ loom.ly/SF2N3Gg
www.syantra.com Syantra | Syantra Announces Liquid Biopsy Platform Breakthrough with Expanded IP Portfolio;... CALGARY, AB. - Today, Syantra, a liquid biopsy platform and innovation company that is changing the way cancer is detected, starting with Syantra DX™ Breast Cancer, announced additions to their... We're proud to share this exciting news... ⬇️ loom.ly/SF2N3Gg